Evidence map›Paper›PMID 40848176›Full record

ArticleEuropean radiology experimental2025

MRI R2* and quantitative susceptibility mapping in brain tissue with extreme iron overload.

Christoph Birkl, Marlene Panzer, Christian Kames, Anna Maria Birkl-Toeglhofer, Alexander Rauscher, Bernhard Glodny, Elke R Gizewski, Heinz Zoller

Abstract read
In one paragraph

Article in European radiology experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christoph BirklDepartment of Radiology, Medical University of Innsbruck, Innsbruck, Austria. christoph.birkl@i-med.ac.at.ORCID http://orcid.org/0000-0003-3101-4002
Marlene PanzerDepartment of Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
Christian KamesDepartment of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada.
Anna Maria Birkl-ToeglhoferInstitute of Neuropathology and Neuromolecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.
Alexander RauscherDepartment of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada.
Bernhard GlodnyDepartment of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
Elke R GizewskiDepartment of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
Heinz ZollerDepartment of Medicine I, Medical University of Innsbruck, Innsbruck, Austria.

Funding

Austrian Science Fund I 6838
6 · The paper itself

Abstract

backgroundR2* and quantitative susceptibility mapping (QSM) are regarded as robust techniques for assessing iron content in the brain. While these techniques are established for normal or moderate iron levels, their usability in extreme iron overload, as seen in aceruloplasminemia (ACP), is unclear. We aimed to evaluate various R2* and QSM algorithms in assessing brain iron levels in patients with ACP compared to healthy controls. MATERIALS AND

methodsWe acquired a three-dimensional multiecho gradient-echo sequence for R2* and QSM in three patients with ACP and three healthy subjects. Six algorithms each for R2* and QSM were compared. QSM was performed with referencing to whole brain, to cerebrospinal fluid and without referencing. R2* and QSM values were assessed in the caudate nucleus, putamen, globus pallidus, and thalamus.

resultsR2* values varied significantly across algorithms, particularly in the putamen (F(5,50) = 16.51, p < 0.001). For QSM, reference region choice (F(5,150) = 264, p < 0.001) and algorithm selection (F(2,9) = 10, p < 0.001) had an impact on susceptibility values. In patients, referencing to whole brain yielded lower susceptibility values than cerebrospinal fluid (median = 0.147 ppm, range = 0.527 ppm versus median = 0.279 ppm, range = 0.593 ppm).

conclusionExtreme iron overload amplifies variability in R2* and QSM measurements. QSM referencing is particularly challenging in diffuse whole-brain iron accumulation; thus, analysis with multiple reference regions might mitigate bias. Both algorithm selection and referencing approaches play a pivotal role in determining measurement accuracy and clinical interpretation under extreme brain iron overload. RELEVANCE STATEMENT: As QSM transitions into clinical use, it will encounter cases of extreme iron overload. Our study in patients with aceruloplasminemia revealed that the choice of reference region significantly influences susceptibility values, with variations exceeding algorithm-dependent differences. KEY POINTS: R2* and QSM vary across algorithms in brain tissue with iron overload. Whole-brain referenced QSM leads to lower susceptibility values in aceruloplasminemia patients. QSM, if properly processed, provides reliable maps in iron overload brain regions. In brain regions with extremely high iron content, R2* mapping might fail.

Indexed as

BrainIron OverloadMagnetic Resonance ImagingNeurodegenerative DiseasesAdultAlgorithmsCeruloplasminFemaleHumansIronIron Metabolism DisordersMaleMiddle AgedCeruloplasminIronBrainCeruloplasminIron overloadMagnetic resonance imagingPutamen

Identifiers

PMID40848176
PMCPMC12374935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.